Normocalcemic parathormone elevation after successful parathyroidectomy

Long-term analysis of parathormone variations over 10 years

Melanie Goldfarb, Stephen Gondek, George L. Irvin, John Lew

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear. Method: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed. Results: Of 96 patients followed ≥10 years, 42 had postoperative NPE. Only male gender (P =.008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred. Conclusion: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.

Original languageEnglish
Pages (from-to)1076-1084
Number of pages9
JournalSurgery
Volume150
Issue number6
DOIs
StatePublished - Dec 1 2011

Fingerprint

Parathyroidectomy
Parathyroid Hormone
Recurrence
Reference Values
Calcium
Intraoperative Monitoring
Primary Hyperparathyroidism

ASJC Scopus subject areas

  • Surgery

Cite this

Normocalcemic parathormone elevation after successful parathyroidectomy : Long-term analysis of parathormone variations over 10 years. / Goldfarb, Melanie; Gondek, Stephen; Irvin, George L.; Lew, John.

In: Surgery, Vol. 150, No. 6, 01.12.2011, p. 1076-1084.

Research output: Contribution to journalArticle

Goldfarb, Melanie ; Gondek, Stephen ; Irvin, George L. ; Lew, John. / Normocalcemic parathormone elevation after successful parathyroidectomy : Long-term analysis of parathormone variations over 10 years. In: Surgery. 2011 ; Vol. 150, No. 6. pp. 1076-1084.
@article{7e704b6fcd6644d29cbc74178b79b444,
title = "Normocalcemic parathormone elevation after successful parathyroidectomy: Long-term analysis of parathormone variations over 10 years",
abstract = "Background: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear. Method: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed. Results: Of 96 patients followed ≥10 years, 42 had postoperative NPE. Only male gender (P =.008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred. Conclusion: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.",
author = "Melanie Goldfarb and Stephen Gondek and Irvin, {George L.} and John Lew",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.surg.2011.09.017",
language = "English",
volume = "150",
pages = "1076--1084",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Normocalcemic parathormone elevation after successful parathyroidectomy

T2 - Long-term analysis of parathormone variations over 10 years

AU - Goldfarb, Melanie

AU - Gondek, Stephen

AU - Irvin, George L.

AU - Lew, John

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear. Method: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed. Results: Of 96 patients followed ≥10 years, 42 had postoperative NPE. Only male gender (P =.008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred. Conclusion: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.

AB - Background: The long-term significance of normocalcemic parathormone elevation (NPE) after successful parathyroidectomy for sporadic primary hyperparathyroidism remains unclear. Method: Of 239 consecutive patients who underwent targeted parathyroidectomy with intraoperative parathormone monitoring, 96 were followed for ≥10 years. NPE was defined as a normal serum calcium level and parathormone (PTH) above the normal reference range ≥6 months after successful parathyroidectomy. Recurrence was defined as elevated serum calcium and PTH levels ≥6 months after parathyroidectomy. Risk factors for NPE, patterns of postoperative PTH variation, and 10-year outcomes were analyzed. Results: Of 96 patients followed ≥10 years, 42 had postoperative NPE. Only male gender (P =.008) was a risk factor for NPE, and NPE did not predict recurrence. Three patterns of postoperative NPE were identified in patients with ≥3 PTH measurements over this 10-year period. Group 1 (n = 11): 1 to 2 consecutive PTH elevations; none recurred, and most were explained by physiologic variation. Group 2 (n = 23): multiple PTH fluctuations; 3 recurred, and almost all had physiologic variations. Group 3 (n = 4): PTH always elevated; 2 recurred. Conclusion: Postoperative NPE may be a dynamic, reversible, and transient clinical entity that does not predict recurrence. Nevertheless, patients with postoperative NPE should be monitored and an attempt made to correct any obvious potential causes of PTH elevation.

UR - http://www.scopus.com/inward/record.url?scp=82755164555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82755164555&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2011.09.017

DO - 10.1016/j.surg.2011.09.017

M3 - Article

VL - 150

SP - 1076

EP - 1084

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -